Add-back therapy for endometriosis in adolescents

被引：0
|
作者：
Lubianca, JN
Gordon, CM
Laufer, MR
机构：
[1] Childrens Hosp, Div Gynecol, Dept Surg, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Med, Div Adolescent Young Adult Med & Endocrinol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
来源：
JOURNAL OF REPRODUCTIVE MEDICINE | 1998年 / 43卷 / 03期
关键词：
endometriosis; GnRH; GnRH agonists; adolescence; bone density; add-back therapy;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
OBJECTIVE: To review the impact of gonadotropin-releasing hormone agonists (GnRH-as) an bone mass in adolescents and options for GnRH-a with "add-back" for long-term therapy for adolescents with endometriosis Mot responding to conventional therapy. STUDY DESIGN: Literature research. RESULTS: The use of GnRH-a plus add-back therapy has not been specifically studied in the adolescent population, and thus the ideal dosage of add-back sar steroids for adolescents has not been delineated. CONCLUSION: GnRH-a plus add-back can be considered for usage in adolescents with endometriosis who are refractory to conventional therapy, but steroids due needed to determine the ideal dosage and long-term effects.
引用
收藏
页码：164 / 172
页数：9
相关论文
共 50 条
  • [21] Add-back therapy in the treatment of endometriosis-associated pain (vol 82, pg 1303, 2004)
    Zupi, E
    Sbracia, M
    De Vivo, B
    Marconi, D
    Zullo, F
    Exacustos, C
    Sorrenti, G
    FERTILITY AND STERILITY, 2005, 83 (04) : 1070 - 1070
  • [22] GNRHA AND STEROID ADD-BACK THERAPY FOR UTERINE MYOMA
    ISHIMARU, T
    SAMEJIMA, T
    MASUZAKI, H
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1995, 48 (02) : 221 - 221
  • [23] Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: Long-term follow-up
    Surrey, ES
    Hornstein, MD
    OBSTETRICS AND GYNECOLOGY, 2002, 99 (05): : 709 - 719
  • [24] Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached?
    Surrey, ES
    FERTILITY AND STERILITY, 1999, 71 (03) : 420 - 424
  • [25] Steroidal 'Add-Back' therapy in patients treated with GnRH agonists
    Freundl, G
    Gödtke, K
    Gnoth, C
    Godehardt, E
    Kienle, E
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 45 : 22 - 30
  • [26] Leuprolide acetate depot and hormonal add-back in endometriosis: A 12-month study
    Marik, JJ
    OBSTETRICS AND GYNECOLOGY, 1998, 91 (05): : 793 - 793
  • [27] Leuprolide acetate depot and hormonal add-back in endometriosis: A 12-month study
    Hornstein, MD
    Surrey, ES
    Weisberg, GW
    Casino, LA
    OBSTETRICS AND GYNECOLOGY, 1998, 91 (01): : 16 - 24
  • [28] Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis A Randomized Controlled Trial
    DiVasta, Amy D.
    Feldman, Henry A.
    Sadler Gallagher, Jenny
    Stokes, Natalie A.
    Laufer, Marc R.
    Hornstein, Mark D.
    Gordon, Catherine M.
    OBSTETRICS AND GYNECOLOGY, 2015, 126 (03): : 617 - 627
  • [29] The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis
    Chwalisz, Kristof
    Surrey, Eric
    Stanczyk, Frank Z.
    REPRODUCTIVE SCIENCES, 2012, 19 (06) : 563 - 571
  • [30] The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis
    Kristof Chwalisz
    Eric Surrey
    Frank Z. Stanczyk
    Reproductive Sciences, 2012, 19 : 563 - 571
12345